Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $14.46B.
ENTERPRISE VALUE (EV)
$14.46B
Ascendis Pharma A/S
Market Cap
$14.16B
Enterprise Value (EV)
$14.46B
Market Cap
$14.97B
Enterprise Value (EV)
$17.80B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Ascendis Pharma A/S (ASND) | $14.16B | $14.46B |
| Tempus AI, Inc. (TEM)vs › | $14.64B | $15.48B |
| Exelixis, Inc. (EXEL)vs › | $14.79B | $14.68B |
| Charles River Laboratories International, Inc. (CRL)vs › | $14.97B | $17.80B |
| Corcept Therapeutics Incorporated (CORT)vs › | $13.19B | $13.09B |
| Solventum Corporation (SOLV)vs › | $15.24B | $20.13B |
| BridgeBio Pharma, Inc. (BBIO)vs › | $12.95B | $14.77B |
| ICON Public Limited Company (ICLR)vs › | $12.89B | $15.45B |
| Baxter International Inc. (BAX)vs › | $12.52B | $20.04B |
| Penumbra, Inc. (PEN)vs › | $12.49B | $12.50B |
Market Cap
$14.16B
Total Debt
$1.02B
Cash
$723.29M
Enterprise Value
$14.46B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
